NCT07017738

Brief Summary

The purpose of this study is to investigate the effect of Neural Mobilization in patients with Upper Cross Syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

June 10, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

June 4, 2025

Last Update Submit

January 7, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Forward head angle

    The forward head angle between the line connecting the tragus and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    6 weeks

  • Rounded shoulder angle

    The rounded shoulder angle between the line between the acromion process and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    6 weeks

  • Kyphosis angle

    For the kyphosis angle, the bone marker on the spinous process of C7 will be used as the starting point of the arch and the spinous process of T12 will be used as the endpoint of the arch. It will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    6 weeks

Secondary Outcomes (1)

  • Boston Questionnaire (Arabic version)

    6 weeks

Study Arms (2)

Neural mobilization + Corrective exercises

EXPERIMENTAL

They will receive neural mobilization in addition to corrective exercises for UCS, 3 times per week for 6 weeks.

Other: Corrective exercisesOther: Neural mobilization

Corrective exercises

ACTIVE COMPARATOR

They will receive corrective exercise for UCS, 3 times per week for 6 weeks.

Other: Corrective exercises

Interventions

The corrective exercise program will include various positions: in standing, scapular retraction and arms overhead; in sitting, chin tuck and thoracic extension; in supine, arms in a W shape and horizontal abduction with external rotation; in side-lying, forward flexion starting with arms parallel to the body; and in prone, scapular retraction and depression in a T shape, extension from 90° forward flexion, and horizontal abduction at 90° with external rotation. Exercises will start with three repetitions held for 10 seconds and progress to six repetitions held for 25 seconds, based on overload principles and individual needs. Participants experiencing pain may stop and rest until symptoms subside.

Corrective exercisesNeural mobilization + Corrective exercises

Median nerve mobilization will be performed with the patient in a supine position, shoulder abducted to 90°, elbow flexed at 90°, and both wrist and head in a neutral position. The therapist will mobilize the nerve by extending the elbow to 45°, while the patient performs ipsilateral cervical lateral flexion to unload the nervous system.

Neural mobilization + Corrective exercises

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranged from 20 to 50 years.
  • Body Mass Index ≤30 kg/m².
  • All participants have a forward head, craniovertebral angle \< 50°.
  • All participants have round back (kyphosis angle ≥ 42°).
  • All participants have rounded shoulders of ≥ 52°.
  • The subjects were chosen from both genders based on an assessment of upper cross syndrome by photogrammetric analysis.
  • All participants have pain intensity level measured by visual analogue scale (4-8).
  • All participants tested positive for upper limb tension test of median nerve.

You may not qualify if:

  • History of trauma or surgery in the cervical region.
  • Bone fractures or acute soft tissue injuries.
  • Osteoporosis.
  • Pregnant women.
  • Cancer.
  • Neurological conditions affecting cervical and thoracic spine.
  • Connective tissue disease: This includes diseases such as osteomyelitis, lupus, and scleroderma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Egypt

Location

MeSH Terms

Conditions

Oculocerebral hypopigmentation syndrome type Preus

Study Officials

  • Abeer Abdelrahman, PhD

    Professor, Cairo university

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 4, 2025

First Posted

June 12, 2025

Study Start

June 10, 2025

Primary Completion

December 10, 2025

Study Completion

December 15, 2025

Last Updated

January 9, 2026

Record last verified: 2026-01

Locations